InvestorsHub Logo
Followers 52
Posts 3354
Boards Moderated 0
Alias Born 10/26/2013

Re: antihama post# 2202

Tuesday, 05/22/2018 10:42:52 AM

Tuesday, May 22, 2018 10:42:52 AM

Post# of 3283
And I'd be remiss if I didn't mention the upcoming basket trial for posi in EGFR and HER2 exon 20 insertion mutations in multiple tumor types where it may be found as another pick me upper to share price. Per Dr Heymach's recent video that would double the # patients that would be treated with pozi to some 40,000.